Did you know? “Head and neck cancer” is a collective term that includes several different types of cancers. Discover how immunotherapy for head and neck cancer is changing the outlook for patients, during #HeadAndNeckCancerAwarenessMonth : bit.ly/3x06Hew #Immunotherapy

Researchers NUS Yong Loo Lin School of Medicine observed that a chemical linked to poor diet or diabetes could increase a person's cancer risk over time. Discover how this study could advance prevention strategies aimed at promoting healthy aging: nus.edu/3vO1HK2 #CancerResearch

What are the most significant developments in targeted therapies and liquid biopsies in recent years? Dr. Bartlett of AHN discusses updates in genomic testing for cancer patients with Targeted Oncology: bit.ly/3TUymFx #ctDNA #LiquidBiopsy #CancerResearch #CancerPatient

“Our findings show that liver cells, with their release of SAA proteins, effectively serve as an immune checkpoint regulating anti-cancer immunity, making them a promising therapeutic target,” says senior author Dr. Beatty Penn PennMedicine PennCancer: bit.ly/4b48Dli

According to a new paper from Wilmot Cancer Institute's Nikesha Gilmore, PhD (she/her/hers), published in JAGS, investigators have inadequately addressed the intersection of aging, health disparities, and cancer outcomes among older adults. Explore with UR Medicine: bit.ly/3W68Ekl #CancerResearch

From September 8-11, leading experts in cancer immunology from around the world will gather at #CICON24 to explore and collaborate on the latest research! Meeting Co-Chair, Dr. Jaffee, of Johns Hopkins Kimmel Cancer Center Johns Hopkins Medicine shares why you should register now: bit.ly/49Bceq8

Researchers from Purdue University are developing a novel immunotherapy to be used against glioblastoma. “These patients urgently deserve better, and more effective, treatment options,' expresses Purdue Pharmacy and Purdue Institute for Cancer Research's Dr. Matosevic: bit.ly/49SAZ0P #Glioblastoma

Through sessions led by Spanish-speaking patients and medical experts, including Dr. Ivy Riano Monsalve Ivy Riano, M.D. Dartmouth Cancer Center, CRI's 2024 Spanish-Language Immunotherapy Patient Summit provides the latest information on immunotherapy: bit.ly/3OsvldN #CRISummit

Colorectal cancer is the second leading cause of cancer death in the US- yet only 44% of Gen X women have been screened. Katie Couric describes the importance of routine screenings and early detection in FORTUNE: bit.ly/3U4hlJo #EarlyDetection #ColorectalCancer

Researchers Virginia Tech developed a new approach to employ cytokine proteins as a potential immunotherapy treatment, ensuring that the cytokines localize within the tumors for weeks, while preserving their structure and reactivity levels: bit.ly/3UqHNy7 #Immunotherapy

Submit your abstract now for one of #CICON24 's dedicated poster sessions! All submissions will be considered, and a limited number of highly ranked abstracts will be chosen for short oral presentations. The deadline for abstract submission is June 3, 2024: bit.ly/3VeUhtv

Researchers Vanderbilt Health, including former CRI CLIP Investigator Dr. Rathmell, have identified cancer cell-specific genetic alterations that reprogram the immune landscape, thereby driving tumor growth, and discovered a potential new drug target to stop it: bit.ly/4b7MPFb

According to a study highlighted in Healio, English proficiency, income, and insurance type could factor the disparity of cervical cancer screenings in women cared for at rural community health centers versus urban centers: bit.ly/3IR6InY #HealthEquity #CancerResearch

How are researchers revolutionizing cancer care with genomic testing? Dr. Bartlett of AHN discusses the utilization and growing importance of genomic testing in cancer care with Targeted Oncology: bit.ly/43F52aK #CancerResearch #CancerCare #TargetedOncology

Join us in a new era of hope and discovery, and double your impact. Your donation will be matched up to $300,000 by a group of generous donors, only until June 30, 2024. Give today, and play a pivotal role in funding the future of cancer immunotherapy: bit.ly/3Pv3FFB

According to The Lancet Commission, experts predict there will be, worldwide, 3 million new breast cancer cases a year and 1 million deaths, with people in low and middle income countries disproportionately affected. More from Cambridge University: bit.ly/4d0dsxC #BreastCancer

Dr. Ayana Ruffin is a tumor immunotherapy rockstar! Cancer Research Institute Winship Cancer Institute of Emory University Paulos Lab Gregory Lesinski

Have you submitted your abstract for #CICON24 ? The submission portal for abstracts is open until June 3! Vinod BalachandranMD Memorial Sloan Kettering Cancer Center shares why you should submit now to secure one of the limited oral presentation slots reserved for top-rated abstracts: bit.ly/3VeUhtv

How has the field of targeted therapies for multiple myeloma evolved in recent years? Dr. Cohen of Penn shares his insights into the field of multiple myeloma with Targeted Oncology: bit.ly/43XFR39 #MultipleMyeloma #CancerResearch #TargetedOncology

Immunotherapy for head and neck cancer provides new treatment options, especially for patients with HPV-related cancers, and without the potentially devastating side effects of conventional treatments. Learn more during #HeadandNeckCancer Awareness Month: bit.ly/3x06Hew